DE69732109D1 - Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten - Google Patents

Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten

Info

Publication number
DE69732109D1
DE69732109D1 DE69732109T DE69732109T DE69732109D1 DE 69732109 D1 DE69732109 D1 DE 69732109D1 DE 69732109 T DE69732109 T DE 69732109T DE 69732109 T DE69732109 T DE 69732109T DE 69732109 D1 DE69732109 D1 DE 69732109D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
tyloxapol
compositions containing
active ingredient
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69732109T
Other languages
English (en)
Other versions
DE69732109T2 (de
Inventor
Thomas P Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charlotte Mecklenburg Hospital
Original Assignee
Charlotte Mecklenburg Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charlotte Mecklenburg Hospital filed Critical Charlotte Mecklenburg Hospital
Application granted granted Critical
Publication of DE69732109D1 publication Critical patent/DE69732109D1/de
Publication of DE69732109T2 publication Critical patent/DE69732109T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69732109T 1996-04-25 1997-04-23 Pharmazeutische Zusammensetzungen die ein Alkylarylpolyetheralkohol-Polymer enthalten Expired - Lifetime DE69732109T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/638,893 US5849263A (en) 1993-03-30 1996-04-25 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
US638893 1996-04-25
PCT/US1997/006862 WO1997039758A1 (en) 1996-04-25 1997-04-23 Pharmaceutical compositions containing alkylaryl polyether alcohol polymer

Publications (2)

Publication Number Publication Date
DE69732109D1 true DE69732109D1 (de) 2005-02-03
DE69732109T2 DE69732109T2 (de) 2005-12-22

Family

ID=24561894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69732109T Expired - Lifetime DE69732109T2 (de) 1996-04-25 1997-04-23 Pharmazeutische Zusammensetzungen die ein Alkylarylpolyetheralkohol-Polymer enthalten

Country Status (9)

Country Link
US (2) US5849263A (de)
EP (1) EP0910390B1 (de)
JP (1) JP2001504438A (de)
AT (1) ATE285782T1 (de)
AU (1) AU2809697A (de)
CA (1) CA2251656C (de)
DE (1) DE69732109T2 (de)
ES (1) ES2234017T3 (de)
WO (1) WO1997039758A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
JP4856809B2 (ja) * 1999-03-31 2012-01-18 シーシーアイ株式会社 皮膚外用剤
US6240313B1 (en) * 1999-04-19 2001-05-29 Cardiac Pacemakers, Inc. Cardiac rhythm management system with prevention of double counting of events
GB0008660D0 (en) * 2000-04-07 2000-05-31 Arakis Ltd The treatment of respiratory diseases
WO2002058610A1 (en) * 2001-01-24 2002-08-01 Summanus Pharma, Inc. Alkyl aryl polyether alcohol polymers for improvement of nasal breathing
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR20170070274A (ko) 2009-05-29 2017-06-21 펄 테라퓨틱스 인코포레이티드 지속형 무스카린 안타고니스트 및 지속형 ｂ₂아드레날린 수용체 아고니스트의 폐 전달용 조성물, 및 연관된 방법 및 시스템
JP6454323B2 (ja) 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2454541A (en) * 1944-09-09 1948-11-23 Rohm & Haas Polymeric detergents
US3272700A (en) * 1963-10-03 1966-09-13 Sterling Drug Inc Stabilized aqueous solution of tetracaine salt
DE1929039C3 (de) * 1968-06-12 1974-08-15 Konishiroku Photo Industry Co., Ltd., Tokio Lichtempfindliche fotografische Silberhalogenidemulsion
US4039669A (en) * 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
US5110806A (en) * 1985-06-26 1992-05-05 The Regents Of The University Of California Lung surfactant compositions
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
US5259963A (en) * 1989-01-12 1993-11-09 Sandoz Ltd. Surface active compositions their production and use
US5134129A (en) * 1989-03-15 1992-07-28 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
ES2097282T3 (es) * 1992-05-26 1997-04-01 Procter & Gamble Composiciones farmaceuticas para uso como estabilizador de mastocitos.
US5362758A (en) * 1992-09-18 1994-11-08 Pfizer Inc. Ophthalmic piroxicam solution
US5849263A (en) * 1993-03-30 1998-12-15 Charlotte-Mecklenburg Hospital Authority Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
CA2102142A1 (en) * 1993-03-30 1994-10-01 Andrew J. Ghio Method of inhibiting oxidants using alkylaryl polyether alcohol polymers
US5840277A (en) * 1993-03-30 1998-11-24 Charlotte Hospital Authority Treatment of chronic pulmonary inflammation
US5830436A (en) * 1993-03-30 1998-11-03 Duke University Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
US5540930A (en) * 1993-10-25 1996-07-30 Pharmos Corporation Suspension of loteprednol etabonate for ear, eye, or nose treatment
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions
US5770585A (en) * 1995-05-08 1998-06-23 Kaufman; Robert J. Homogeneous water-in-perfluorochemical stable liquid dispersion for administration of a drug to the lung of an animal
EP0780127A1 (de) * 1995-12-19 1997-06-25 The Procter & Gamble Company Nasenspray enthaltend einen Steroid und einen Antihistamin
US6037328A (en) * 1998-12-22 2000-03-14 Bausch & Lomb Incorporated Method and composition for rewetting and preventing deposits on contact lens

Also Published As

Publication number Publication date
US5849263A (en) 1998-12-15
WO1997039758A1 (en) 1997-10-30
ATE285782T1 (de) 2005-01-15
AU2809697A (en) 1997-11-12
JP2001504438A (ja) 2001-04-03
CA2251656C (en) 2008-07-08
CA2251656A1 (en) 1997-10-30
ES2234017T3 (es) 2005-06-16
DE69732109T2 (de) 2005-12-22
US6165445A (en) 2000-12-26
EP0910390A1 (de) 1999-04-28
EP0910390B1 (de) 2004-12-29

Similar Documents

Publication Publication Date Title
CA2203033A1 (en) Compounds and compositions for delivering active agents
CA2133177A1 (en) Rapamycin formulations for oral administration
CA2031572A1 (en) Non-alcoholic delivery system for orally ingestible active ingredients
IL117889A0 (en) Pharmaceutical compositions containing lipophilic compounds
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
NZ318282A (en) Pharmaceutical formulation containing amoxycillin and clavulanate in a weight ratio of 12:1 and 20:1
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
FI955403A (fi) Valeltavia koostumuksia, jotka sisältävät polymeerimateriaalia, glykoleja ja glyseridejä
DE69430070D1 (de) Topische pharmazeutische zusammensetzungen die (s)-2-(4-isobutylphenyl) propionsaeure enthalten
DE69732109D1 (de) Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
IT1255968B (it) Composizioni farmaceutiche contenenti acido ursodesossicolico
KR950007857A (ko) 경구투여용 라파마이신 제제
BR9509517A (pt) Composição lipossômica composição farmacéutica e processo para a preparação de composições lipossómicas
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
IT1250672B (it) Formulazioni orali di ubidecarenone in soluzione acquosa
ATE173624T1 (de) Synergistische pharmazeutische zusammensetungen, die triamcinolonacetonid und halcinonid enthalten
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
EP0356264A3 (de) Reiningungsmittel für die örtliche Desinfektion
JP2000319171A (ja) 殺菌性皮膚外用剤組成物
FR2604903B1 (fr) Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
EP0558721B1 (de) Reichstoffzusammensetzungen
EP0056681A3 (de) Formulierungen des Levonantradols und N-Methyllevonantradols
DE69902925D1 (de) Ramoplaninhaltige neue injizierbare arzneizubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition